Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02448303
Brief Title: Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer (KEYNOTE166)

First Submitted : May 14, 2015
First Submitted that Met QC Criteria : May 15, 2015
First Posted : May 19, 2015 (Estimate)

Results First Submitted : July 19, 2019
Results First Submitted that Met QC Criteria : August 22, 2019
Results First Posted : September 12, 2019

Last Update Submitted that Met QC Criteria : August 22, 2019
Last Update Posted : September 12, 2019